| Also known as |
BAY 43-9006 |
| Blood pressure |
Can cause hypertension |
| Chemical name |
4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpyridine-2-carboxamide |
| Dosage (medical) |
Typically 400 mg twice daily |
| Dosage (sports) |
Not applicable |
| Effects |
Inhibits tumor cell proliferation and angiogenesis |
| Formula |
C21H16ClF3N4O3 |
| Half-life |
Approximately 25 to 48 hours |
| Hepatotoxicity |
Yes, can cause liver injury |
| Lab Test |
Liver function tests are recommended |
| Main action |
Antineoplastic agent |
| Side effects |
Diarrhea, rash, fatigue, hypertension, hand-foot skin reactions |
| Storage conditions |
Store at room temperature, protect from moisture |
| Strength |
200 mg |
| Substance class |
Kinase inhibitor |
| Trade name |
Nexavar |
| Use in sports |
None |
| Water Retention |
Minimal |
| Manufacturer |
Natco Pharmaceuticals Ltd. |
